申请人:ASIERIS PHARMACEUTICAL TECHNOLOGIES CO., LTD.
公开号:US20160031819A1
公开(公告)日:2016-02-04
Novel base addition salts of nitroxoline with improved solubility and increased urine secretion under physiological conditions are described. Pharmaceutical compositions and methods of treatment using the pharmaceutical compositions are also described.
本发明描述了一种改善溶解度和在生理条件下增加尿液分泌的硝氧氮化物的新型基础盐。还描述了制药组合物和使用制药组合物的治疗方法。